U.S. Lifts NVIDIA China Restrictions, Restoring 25% of Revenue Pipeline
The U.S. has approved Chinese companies to buy NVIDIA chips, lifting all export restrictions and trading bans that previously blocked a quarter of the company's annual revenue. The move signals a potential thaw in AI chip trade tensions and lifts semiconductor and AI infrastructure plays.
RKey facts
- All NVIDIA export restrictions to China lifted; U.S. approves Chinese chip purchases
- China represented 25% of NVIDIA's revenue before trade restrictions
- Lift announced amid Trump-Xi summit discussions on trade rebalancing
- Move supports continued AI infrastructure capex cycle globally
What's happening
A significant development in U.S.-China AI relations emerged this week as reports confirmed the U.S. has lifted export restrictions on NVIDIA chips for Chinese purchasers. China represented roughly 25% of NVIDIA's total revenue before restrictions were imposed, making the reinstatement of trade access a material catalyst for the chipmaker and broader AI infrastructure buildout narrative. The approval signals a potential softening in technology trade barriers that have defined the Trump administration's approach to China competition.
While the White House has not yet issued formal statements detailing the scope or timeline of the lifting, market participants are interpreting this move as aligned with broader U.S.-China summit discussions in Beijing where Presidents Trump and Xi Jinping met to discuss trade rebalancing. The timing coincides with reports that China would commit to billions in additional American agricultural and energy purchases, suggesting a more balanced trade posture emerging from high-level talks.
The implication for equity markets is straightforward: NVIDIA's AI infrastructure revenue moatA sustainable competitive advantage that protects long-term returns on capital. expands at a moment when the broader chip sector is already rallying on expectations of sustained AI capex cycles. Broadcom, Advanced Micro Devices, and other semiconductor suppliers could see secondary benefit from renewed Chinese demand for AI-adjacent components. The move also underscores that AI infrastructure demand transcends geopolitical friction, with both the U.S. and China incentivized to maintain supply chains for the technology buildout that both economies view as strategically critical.
Skeptics warn that formal regulatory approval and actual commercial execution can lag by months, and that future trade policy shifts remain unpredictable. Additionally, Chinese domestic chipmakers have been ramping production to reduce reliance on U.S. exports, so the revenue recovery for NVIDIA may be more gradual than the headline suggests.
What to watch next
- 01NVIDIA Q2 earnings guidanceCompany-issued forecasts of future financial performance. for China revenue recovery: June
- 02Formal regulatory filing details from U.S. Department of Commerce: next weeks
- 03Chinese AI chipmaker competitive response and capex acceleration: ongoing
- PR Newswire FinancialEightco Holdings (NASDAQ: ORBS) dichiara un portafoglio complessivo di circa 340 milioni di dollari, che comprende OpenAI, Beast Industries, oltre 11.000 ETH e più di 283 milioni di token WLD
Composizione della tesoreria di Eightco al 12 maggio 2026: 90 milioni di dollari in azioni OpenAI (indirette), 18 milioni di dollari in azioni Beast Industries, 11.068 ETH, 283 milioni di WLD e 129 milioni di dollari in contanti e mezzi equivalenti, per un totale di circa 340 milioni di...
1h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Willis Towers Watson plc - WTW
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Willis Towers Watson plc ("Willis Towers Watson" or the "Company") (NASDAQ: WTW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
4h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Blaize Holdings, Inc. - BZAI
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Blaize Holdings, Inc. ("Blaize" or the "Company") (NASDAQ: BZAI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
4h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Corporation - MRBK
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Meridian Corporation ("Meridian" or the "Company") (NASDAQ: MRBK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
4h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of JetBlue Airways Corporation - JBLU
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of JetBlue Airways Corporation ("JetBlue" or the "Company") (NASDAQ: JBLU). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
4h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass Therapeutics, Inc. - CMPX
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Compass Therapeutics, Inc. ("Compass" or the "Company") (NASDAQ: CMPX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
4h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sportradar Group AG - SRAD
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sportradar Group AG ("Sportradar" or the "Company") (NASDAQ: SRAD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
4h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Grace Therapeutics, Inc. - GRCE
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Grace Therapeutics, Inc. ("Grace" or the "Company") (NASDAQ: GRCE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
4h ago
Related coverage
- US Lifts All Export Restrictions on Nvidia Chips to China: 25% Revenue Stream RestoredTech & AI··0 mentions
- US Lifts China AI Chip Export Bans: Nvidia Revenue Boost, Geopolitical FlipTech & AI··0 mentions
- US Lifts China Chip Export Restrictions, NVDA 25% Revenue Exposure UnlockedTech & AI··0 mentions
- US Government Approves Nvidia H200 Sales to 10 Chinese Firms; Chip War EasingTech & AI··0 mentions
More about $NVDA
- S&P 500 and Nasdaq Hit Records While Breadth Stalls: AI Mega-Caps Carry Market, Active Managers Lag·Equities US
- AI Buildout Spreading Beyond Chips Into Networking, Robotics, and Data Centers: Cisco, Meta Deals Signal Capex Acceleration·Tech & AI
- Trump-Xi Beijing Summit Drives Trade Truce Optimism: Agricultural, Oil, and Tech Negotiations In Play·Equities US
- US Lifts All Export Restrictions on Nvidia Chips to China: 25% Revenue Stream Restored·Tech & AI
- US Lifts China AI Chip Export Bans: Nvidia Revenue Boost, Geopolitical Flip·Tech & AI
Live coverage of the AI semiconductor cycle — NVDA, AVGO, AMD, ASML, memory demand, capex run rates and overbought signals.